CapsoVision (CV) Capital Expenditures (2024 - 2025)

CapsoVision (CV) posted Capital Expenditures of -$154000.0 for Q4 2024, down 198.72% sequentially from $156000.0 in Q3 2024.

CapsoVision (CV) Capital Expenditures (2024 - 2025) Analysis & Trends

CapsoVision has reported Capital Expenditures for 1 years, with the latest figure at -$154000.0 in Q4 2024.

Quarterly Capital Expenditures changed N/A year-over-year to -$154000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $2000.0 (changed N/A YoY) and the FY2024 annual result came in at -$1000.0, changed N/A from the prior year.
Capital Expenditures retreated to -$154000.0 in Q4 2024 per CV's latest filing, from $156000.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $156000.0 in Q3 2024 and troughed at -$154000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	497.00 Mn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	202.00 Mn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	488.00 Mn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	195.00 Mn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	66.90 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	84.70 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	100.00 Mn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	-74.39 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	87.50 Mn
10	CapsoVision	295.13 Mn	286.05 Mn	1.87 Mn	-

Download Data